Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2A Safety and Biomarker Study of EPI-589 in Mitochondrial Subtype and Idiopathic Parkinson's Disease
2015-001786-10Phase 2Completed
- Sponsor
- Bioelectron
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of EPI-589 in Parkinson's disease (PD), sponsored by Bioelectron. Primary endpoint: Safety as assessed by drug-related adverse events. Started Nov 2015; status: completed.
02
Drugs
EPI-589
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2015-001786-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001786-10.